Increased risk of torsade de points - aminophylline, clarithromycin
Increased risk of serotonin syndrome - SSRIs, MAOIs
Narrow therapeutic window and high toxicity risk:
Monitor plasma lithium levels, should be 0.4-1 mmol/L
When starting lithium - weight, FBC, U+Es, TFTs, eGFR and ECG
Check serum lithium levels 1 weeks after initiation and after every dose adjustment
Blood lithium levels should be checked 12 hours after last dose
Ongoing monitoring:
Check renal function and TFTs every 6 months
Annual measurement of blood pressure, weight and BMI
Common side effects:
Fine tremor
Thirst and polyuria - nephrogenic diabetes insipidus
Weight gain
Taste disturbance - metallic taste
Hypothyroidism
Goitre
Rare side effects:
Lithium toxicity
Leucocytosis - raised WCC
Lithium toxicity:
Anorexia
Nausea and vomiting
Nystagmus
Coarse tremor
Dysarthria
Ataxia
Severe cases - LOC, seizures and death
Why and how to take:
Lithium works as a mood stabiliser and is advisable that lithium therapy is not started unless there is an intention to continue for 3 years - poor compliance may precipitate rebound mania
Patient should take dose at same time each day
If miss dose - do not double dose, take next dose as prescribed
Counselling:
Take same time each day, do not double dose
Stay hydrated and do not make dietary changes - avoid depletion of sodium
Do not stop taking lithium without discussion with doctor - risk of relapse
Blood tests - regular blood tests at start of treatment, once stable every 3 months
Sings of toxicity
Treatment card
Withdrawal
Contraception
Lithium treatment card:
Advise patient to carry their lithium treatment card and alert card
Show all healthcare professionals this card prior to treatment, including dentists and any over the counter medicines
Same brand:
It is important that the patient is maintained on the same formulation of lithium during treatment, once they are stable
Advise patient to check the brand of the lithium they are prescribed
Withdrawal:
If lithium should be withdrawn, it should be done gradually and under medical supervision
Contraception:
Lithium is a teratogenic drug and so should be avoided in pregnant women
Should only be considered in pregnant women if the therapeutic benefit outweighs the risk of harm to the unborn child
Sexually active females of child-bearing age are advised to use contraception